BPA - Laboratory Supplies/Reagents - Crownpoint Healthcare Facility
Indian Health Service · NAVAJO AREA INDIAN HEALTH SVC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75H71026Q00179 in this department, oldest first.
- Jun 5, 2026Pre-solicitationOpen
- Aug 31, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Solicitation no. 75H71026Q00179 is issued as a/an Request for Quotation (RFQ) for the provision of laboratory supplies, reagents, diagnostic test kits, collection supplies, quality control materials and related laboratory consumables for the Crownpoint Healthcare Facility Laboratory, The North American Industry Classification System (NAICS) is 325413 � In-Vitro Diagnostic Substances Manufacturing � 1250 employees This acquisition is a 100% Indian Small Business Economic Enterprise (ISBEE) set-aside under the Buy Indian Act. This solicitation incorporates provisions and clauses by reference. Th… (show all)
e full text of provisions and clauses may be accessed electronically at www.acquisition.gov and www.acquisition.gov/hhsar. Offerors shall review the attached Combined Synopsis/Solicitation for complete requirements, submission insturctions, evaluation factors, and terms and condititions. Attachment 1 - Laboratory Supply Evaluation Schedule provides the representative items for quotation and evaluation, and Attachment 2 - Stattement of Work (SOW) provides the Government's requirements. The supply list is representative and not all-inclusive; order will be placed on an as-needed basis based on actual laboratory requirements. Brand Name: Unless otherwise specifically identified in the SOW or Attachment 1, manufacturer names and part numbers are provided for identification and evaluation purposes. Equivalent products may be offered, subject to Government determination of technical acceptability. The period of performance (or delivery) is: Base Period: October 1, 2026, through September 30, 2027 Option Period One: October 1, 2027, through September 30, 2028 Delivery shall be FOB Destination to the Crownpoint Healthcare Facility, Crownpoint, New Mexico 87313 Supplies shall be delivered within the delivery times proposed in the Contractor�s quotation and accepted by the Government. The Contractor shall promptly notify the Government of anticipated delays or backorders.
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Indian Health Service), same product/service code (PSC) 6550.
Single-winner award sizes (4): middle half $65K to $114K, median $80K; range $22K to $215K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $2.7B | 2 | $160K | May 28, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $215K | Sep 11, 2026 |
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 1 | $22K | Jan 8, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $QDEL reported $2.7B revenue (12 months to Jun 28, 2026). The median single-winner award in these 4 past awards, $80K, is under 0.1% of that. SEC filing
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 4 past awards, $80K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 11, 2026GOVERNMENT SCIENTIFIC SOURCE INC$215KLaboratory Quality Control Materials - Zuni Comprehensive Community Health Center (ZCCHC)No listed company matched (Materiality N/A)
- May 28, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low) SEC
- May 19, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low) SEC
- Jan 8, 2025ABBOTT LABORATORIES INC.$22KLimited Sources Justification (LSJ): Firm Fixed-Price, Non-Personal Service Type, Commercial Item DO/TO to provide Immunoassay Reagents, Supplies, and Cost Per Reportable Result Analyzer Services for Materiality: <0.01% of $ABT revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Indian Health Service since 2024 (0 filings)
- 0 of their lobbyists list a past Indian Health Service job
- $124K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, House Committee on Natural Resources, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 2 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.